{
    "Title": "Epetraborole, a leucyl-tRNA synthetase inhibitor, demonstrates murine efficacy, enhancing the in vivo activity of ceftazidime against Burkholderia pseudomallei, the causative agent of melioidosis",
    "URL": "https://doi.org/10.1371/journal.pntd.0011795",
    "Published": "November 27, 2023",
    "Subject_Areas": [
        "Burkholderia pseudomallei",
        "Melioidosis",
        "Drug therapy",
        "Animal models of infection",
        "Mouse models",
        "Burkholderia infection",
        "Drug discovery",
        "Spleen"
    ],
    "Authors": {
        "Jason E. Cummings": [
            "Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America"
        ],
        "Christopher S. Lunde": [
            "AN2 Therapeutics, Menlo Park, California, United States of America"
        ],
        "M. R. K. Alley": [
            "AN2 Therapeutics, Menlo Park, California, United States of America"
        ],
        "Richard A. Slayden": [
            "Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America"
        ]
    }
}